Trials / Sponsors / CytoSorbents, Inc
CytoSorbents, Inc
Industry · 9 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CytOSorb TreatMent Of Critically Ill PatientS Registry Septic Shock, Acute Respiratory Distress Syndrome, Trauma | — | 2022-06-22 |
| Terminated | Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D) Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical | N/A | 2021-12-27 |
| Recruiting | Safe and Timely Antithrombotic Removal (STAR) Registry Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical | — | 2021-09-30 |
| Completed | Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) Hemorrhage, Surgical, Blood Loss, Surgical, Blood Loss, Postoperative | N/A | 2021-08-31 |
| Completed | Registry of CytoSorb Therapy in COVID-19 ICU Patients COVID-19 | — | 2020-08-28 |
| Terminated | Ticagrelor CytoSorb Hemoadsorption Emergent Cardiothoracic Surgery, Bleeding, Drug Removal | N/A | 2019-10-29 |
| Terminated | CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery Elective Cardiac Surgery | N/A | 2018-04-19 |
| Completed | CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery Elective Cardiac Surgery | N/A | 2015-11-01 |
| Withdrawn | Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis Rhabdomyolysis | Phase 2 | 2014-03-01 |